The present invention provides a compound of formula (I): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula (I), and pharmaceutical compositions comprising such compounds.
本发明提供了一种公式(I)的化合物:如本文所述,以及药用可接受的盐、对映异构体、旋转异构体、互变异构体或外消旋混合物。还提供了使用公式(I)的化合物治疗由
PIM激酶介导的疾病或状况的方法,以及包含这些化合物的药物组合物。